INTEST CORP (INTT) › Cash & EquivalentsINTEST CORP (INTT) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2009: $2.65M2010: $6.89M2011: $13.96M2012: $15.58M2013: $19.02M2014: $23.13M2015: $25.71M2016: $28.61M2017: $13.29M2018: $17.86M2019: $7.61M2020: $10.28M2021: $21.20M2022: $13.43M2023: $45.26M2024: $19.83M2025: $14.22M$14.22M2009Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$14.22M-28.3%2024$19.83M-56.2%2023$45.26M+236.9%2022$13.43M-36.6%2021$21.20M+106.2%2020$10.28M+35.0%2019$7.61M-57.4%2018$17.86M+34.4%2017$13.29M-53.5%2016$28.61M+11.3%2015$25.71M+11.2%2014$23.13M+21.6%2013$19.02M+22.1%2012$15.58M+11.6%2011$13.96M+102.4%2010$6.89M+160.5%2009$2.65M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share